CanSino Biologics Inc. (OTCMKTS:CASBF) Sees Significant Drop in Short Interest

CanSino Biologics Inc. (OTCMKTS:CASBF) was the recipient of a large decline in short interest in August. As of August 15th, there was short interest totalling 1,157,000 shares, a decline of 6.9% from the July 31st total of 1,243,300 shares. Based on an average daily volume of 100 shares, the short-interest ratio is presently 11,570.0 days.

CanSino Biologics Trading Down 17.5 %

OTCMKTS CASBF opened at C$1.98 on Monday. CanSino Biologics has a twelve month low of C$1.86 and a twelve month high of C$3.55. The firm’s 50 day moving average price is C$2.34 and its two-hundred day moving average price is C$2.26.

CanSino Biologics Company Profile

CanSino Biologics Inc develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N.